Hemostemix Inc. (CVE:HEM – Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 37500 shares trading hands. The stock had previously closed at C$0.08. Hemostemix Stock Down 6.7 % The firm has a market cap of […]
Hemostemix Inc. (CVE:HEM – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.07 and last traded at C$0.07, with a volume of 37500 shares changing hands. The stock had previously closed at C$0.08. Hemostemix Stock Down 6.7 % The business’s 50-day simple moving […]
Hemostemix Inc. (CVE:HEM – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 18700 shares changing hands. The stock had previously closed at C$0.08. Hemostemix Price Performance The firm has a market […]
Hemostemix Inc. is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company s Phase II randomized clinical trial results today.The publication.
Hemostemix Inc.: Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.